YOLFTbeta
60

Guobang Pharma Ltd

605507 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

15.44CNY-0.03 (-0.19%)

Price History

Full chart

Market Stats

Previous Close15.47
Open15.42
Day Range15.29 – 15.62
52-Week Range14.34 – 20.82
Volume4.69M
Market Cap14.15B
P/E (TTM)19.66
Forward P/E0.00
EPS0.92
Dividend Yield2.37%
Beta0.18
50-Day Avg16.36
200-Day Avg17.28

About

Guobang Pharma Ltd. engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries. The company offers pharmaceutical products, including quinolones, macrolides, cephalosporins, characteristic APIs, preparations and accessories, and key pharmaceutical intermediates; and mobile protection APIs, kinetophoretic preparations, and feed additives. It sells its products approximately in 117 countries and regions worldwide. The company was founded in 1996 and is based in Xinchang, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Shixue Liao
  • Employees4.25K
  • HeadquartersNo. 60 Xingmei Avenue, Xinchang, China, 312500, China
  • Websitehttps://www.gbgcn.com

Leadership

  • Mr. Shixue LiaoPresident & Director · b. 1975
  • Mr. Xing Cheng ShiCFO & Accounting Supervisor · b. 1977
  • Ms. Fangfang LuVice President · b. 1977
  • Mr. Qibin LiVP & Director · b. 1983
  • Mr. Ligao YaoVP & Director · b. 1976
  • Mr. Deguang PengBoard Secretary · b. 1991

Financials

Income Statement

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue2.91B3.28B3.80B4.21B4.51B5.72B5.35B5.89B6.01B
Growth (%)-+12.86%+15.95%+10.63%+7.11%+26.98%-6.49%+10.12%+2.05%
Cost of Revenue2.08B2.36B2.84B2.80B3.21B4.19B4.14B4.46B4.45B
Gross Profit821.85M919.73M963.24M1.41B1.29B1.53B1.21B1.44B1.56B
Gross Margin28.29%28.05%25.33%33.45%28.72%26.76%22.60%24.37%26.03%
Operating Expense352.52M340.04M381.65M470.87M485.05M478.18M506.59M540.27M602.98M
Operating Income469.33M579.69M581.59M936.12M808.77M1.05B702.26M895.07M961.88M
Operating Margin16.15%17.68%15.30%22.26%17.95%18.40%13.13%15.19%16.00%
EBITDA619.89M708.96M708.00M1.16B1.02B1.21B950.43M1.27B1.45B
EBITDA Margin21.34%21.62%18.62%27.62%22.56%21.15%17.77%21.55%24.17%
Net Income177.73M210.87M314.94M810.00M706.03M920.90M612.46M781.60M820.82M
Net Income Margin6.12%6.43%8.28%19.26%15.67%16.10%11.45%13.27%13.65%
R&D94.73M103.30M124.34M137.19M155.27M197.54M190.51M215.48M209.83M
R&D as % of Total Revenue3.26%3.15%3.27%3.26%3.45%3.45%3.56%3.66%3.49%
Interest Expense5.04M33.21M33.74M47.04M31.95M20.08M27.54M32.58M23.92M
Interest Expense % of Total Revenue0.17%1.01%0.89%1.12%0.71%0.35%0.51%0.55%0.40%

Balance Sheet

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets4.02B4.37B4.76B5.51B7.51B9.04B10.36B10.78B10.98B
Total Liabilities1.82B1.77B2.14B2.23B1.17B1.89B2.92B2.73B2.43B
Total Equity1.08B1.25B2.62B3.27B6.35B7.16B7.43B8.05B8.55B
Cash946.14M1.00B1.11B1.23B893.01M1.97B2.09B1.91B1.46B
Total Debt697.97M608.12M900.60M910.66M160.17M655.57M934.39M321.86M-
Net Debt-248.18M-393.80M-214.21M-323.94M-732.84M-1.32B-1.13B-1.59B-

Cash Flow

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow148.03M541.68M440.86M767.70M-176.18M1.02B516.76M706.41M559.28M
Investing Cash Flow-77.20M-146.19M-307.34M-365.23M-1.69B-411.76M-353.27M-513.85M-
Financing Cash Flow-97.75M-214.24M-47.02M-273.86M1.57B366.95M-54.14M-386.49M-
Capital Expenditure169.48M163.24M605.18M520.16M448.04M803.12M748.44M419.12M277.71M
Free Cash Flow-21.44M378.44M-164.32M247.55M-624.23M213.92M-231.68M287.29M281.57M
Dividends Paid46.41M31.35M34.06M152.00M279.41M111.76M361.64M194.10M359.63M
FCF to OCF-14.49%69.86%-37.27%32.24%354.31%21.03%-44.83%40.67%50.34%
Dividend Paid to FCF-216.41%8.28%-20.73%61.40%-44.76%52.25%-156.09%67.56%127.72%

Earnings

Report DateSep 30, 2021Dec 31, 2021Apr 28, 2022Aug 21, 2022Oct 19, 2022Dec 31, 2022Apr 14, 2023Jul 28, 2023
EPS Estimate--------
EPS Actual0.260.330.360.530.400.360.350.29
Surprise--------
Timing--After-hoursPre-marketAfter-hours-Pre-marketPre-market

Key Statistics & Ratios

Market Cap14.15B
Enterprise Value13.24B
Trailing P/E19.66
Forward P/E0.00
Price / Sales2.31
Price / Book1.75
EPS0.92
Book Value10.88
Revenue (TTM)6.13B
Gross Profit (TTM)1.46B
EBITDA1.30B
Profit Margin11.53%
Operating Margin12.65%
Return on Equity8.56%
Return on Assets4.60%
Shares Outstanding782.35M
Shares Float315.48M
Beta0.18
Dividend Yield2.37%
Dividend Rate0.43
Payout Ratio46.73%

Dividends

20261×
0.43May 29, 2026
20251×
0.43Jun 13, 2025
20241×
0.22Jun 14, 2024
20231×
0.43May 22, 2023
20221×
0.14Jun 10, 2022
20211×
0.36Nov 17, 2021

Stock Splits

  • May 29, 20261.4:1